Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q2 2023 Earnings Call Transcript August 8, 2023
Mirati Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.04 EPS, expectations were $3.23.
Operator: Good afternoon, and welcome to the Mirati Therapeutics Second Quarter 2023 Earnings Call. My name is Justin, and I will be the operator for today’s call. All lines have been placed on mute to prevent any background noise. After the conclusion of the speakers’ prepared remarks, there...
